Citation Tools

Download PDFPDF

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre, randomised controlled trial

Download to a citation manager

Cite this article as:
Meersch M, Küllmar M, Wempe C SepNet Critical Care Trials Group, et al
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre, randomised controlled trial